Acta Chir Orthop Traumatol Cech. 2025; 92(1):21-27 | DOI: 10.55095/achot2024/070
Modern Approach to the Use of Aspirin in Prevention of Venous Thromboembolism Following Total Hip Arthroplasty or Total Knee Arthroplasty. A Retrospective TrialOriginal papers
- 1 Department of Joint Arthroplasty, "Yonatan" Center-Israeli Joint and Spine Health Center, Tel Aviv-Yafo, Israel
- 2 Assuta Medical Center, Be'er Sheva, Israel
- 3 Assuta Medical Center in Ramat HaHayal, Tel Aviv-Yafo, Israel
- 4 Orthopedic department of Soroka Medical Center, Be'er Sheva, Israel
Purpose of the study: Given the risk of venous thromboembolism (DVT) and pulmonary embolism (PE) after large joint replacement, the role of thromboprophylaxis is crucial. This retrospective study aims to evaluate the effectiveness of aspirin as thromboprophylaxis in patients undergoing TKA or THA.
Material and methods: In this retrospective review of a database of patients who underwent total hip and total knee replacements between 2021 and 2023, we divided patients into two groups: those with no anticoagulation therapy before surgery and those on chronic anticoagulant use prior to surgery. The primary endpoint was the number of patients with complications after aspirin use in the postoperative period. We collected patient demographic information, history of anticoagulant use, postoperative anticoagulant usage, comorbidities, type of surgery, reactions to anticoagulants, complications related to thromboembolism, length of hospital stay, and hospital readmissions.
Results: For patients who underwent elective THA or TKA, no significant difference in overall VTE or PE rates was detected when comparing aspirin with other anticoagulants. No mortality events were reported. However, there were differences in bleeding event rates between the aspirin group and other anticoagulant groups.
Conclusions: Proper patient selection and early postoperative mobilization support the use of aspirin as a thromboprophylaxis therapy. The results of this study confirm that aspirin is a safe alternative to other anticoagulants in the postoperative management of THA and TKA.
Keywords: total hip arthroplasty, total knee arthroplasty, thromboprophylaxis, aspirin
Received: December 29, 2023; Revised: December 29, 2023; Accepted: December 5, 2024; Published: March 13, 2025 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- An VV, Phan K, Levy YD, Bruce WJ. Aspirin as thromboprophylaxis in hip and knee arthroplasty: A systematic review and meta-analysis. J Arthroplasty. 2016;31:2608-2616.
Go to original source...
Go to PubMed...
- Anderson D, Dunbar M, Murnaghan J, Kahn S, Gross P, Forsythe M, Pelet S, Fisher W, Belzile E, Dolan S, Crowther M, Bohm E, MacDonald SJ, Gofton W, Kim P, Zukor D, Pleasance S, Andreou P, Doucette S, Theriault C, Abianui A, Carrier M, Kovacs MJ, Rodger MA, Coyle D, Wells PS, Vendittoli PA. Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty. N Engl J Med. 2018;378:699-707.
Go to original source...
Go to PubMed...
- Azboy I, Groff H, Goswami K, Vahedian M, Parvizi J. Low-dose aspirin is adequate for venous thromboembolism prevention following total joint arthroplasty: a systematic review. J Arthroplasty. 2020;35:886-892.
Go to original source...
Go to PubMed...
- Baumgartner C, Maselli J, Auerbach A, Fang M. Aspirin compared with anticoagulation to prevent venous thromboembolism after knee or hip arthroplasty: A large retrospective cohort study. J Gen Intern Med. 2019;34:2038-2046.
Go to original source...
Go to PubMed...
- Bozic KJ, Vail TP, Pekow PS, Maselli JH, Lindenauer PK, Auerbach AD. Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients? J Arthroplasty. 2010;25:1053-1060.
Go to original source...
Go to PubMed...
- Dai W, Lin Z, Shi Z, Wang J. Venous thromboembolic events after total knee arthroplasty: which patients are at a high risk? J Knee Surg. (Epub 2019), 2020;33:947-957.
Go to original source...
Go to PubMed...
- Faour M, Piuzzi N, Brigati D, Klika A, Mont M, Barsoum W, Higuera C. Low-dose aspirin is safe and effective for venous thromboembolism prophylaxis following total knee arthroplasty. J Arthroplasty. 2018;33:S131-S135.
Go to original source...
Go to PubMed...
- Faour M, Piuzzi N, Brigati D, Klika A, Mont M, Barsoum W, Higuera C. No difference between low- and regular-dose aspirin for venous thromboembolism prophylaxis after THA. Clin Orthop Relat Res. 2019;477:396-402.
Go to original source...
Go to PubMed...
- Falck-Ytter Y, Francis C, Johanson N, Curley C, Dahl O, Schulman S, Ortel T, Pauker S, Colwell C Jr. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e278S-e325S.
Go to original source...
- Heckmann N, Piple A, Wang J, Richardson M, Mayfield C, Oakes D, Christ A, Lieberman J. Aspirin for venous thromboembolic prophylaxis following total hip and total knee arthroplasty: An analysis of safety and efficacy accounting for surgeon selection bias. J Arthroplasty. 2023;38:S412-S419.
Go to original source...
Go to PubMed...
- Hirsh J, Hull R, Raskob G. Clinical features and diagnosis of venous thrombosis. J Am Coll Cardiol. 1986;8:114B-127B.
Go to original source...
Go to PubMed...
- Jameson S, Baker P, Charman S, Deehan D, Reed M, Gregg P, Van der Meulen J. The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement: a non-randomised comparison using National Joint Registry Data. J Bone Joint Surg Br. 2012;94:914-918.
Go to original source...
Go to PubMed...
- Kellgren J, Lawrence J. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494-502.
Go to original source...
Go to PubMed...
- Kovalenko B, Bremjit P, Fernando N. Classifications in brief: Tönnis classification of hip osteoarthritis. Clin Orthop Relat Res. 2018;476:1680-1684.
Go to original source...
Go to PubMed...
- Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780-785.
Go to original source...
Go to PubMed...
- Matharu G, Kunutsor S, Judge A, Blom A, Whitehouse M. Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med. 2020;180:376-384.
Go to original source...
Go to PubMed...
- Morris G, Henry A, Preston B. Prevention of deep-vein thrombosis by low-dose heparin in patients undergoing total hip replacement. Lancet. 1974;304:797-800.
Go to original source...
Go to PubMed...
- National Guideline Centre (UK). Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. London: National Institute for Health and Care Excellence (NICE); 2018 Mar.PMID: 29697228.
- Santana DC, Emara AK, Orr MN, Klika AK, Higuera CA, Krebs VE, Molloy RM, Piuzzi NS. An update on venous thromboembolism rates and prophylaxis in hip and knee arthroplasty in 2020. Medicina (Kaunas). 2020;56:416.
Go to original source...
Go to PubMed...
- Sharda A, Fatovic K, Bauer K. Aspirin thromboprophylaxis in joint replacement surgery. Res Pract Thromb Haemost. 2022;6:e12649.
Go to original source...
Go to PubMed...
- Warren J, Sundaram K, Anis H, Kamath A, Higuera C, Piuzzi N. Have venous thromboembolism rates decreased in total hip and knee arthroplasty? J Arthroplasty. 2020;35:259-264.
Go to original source...
Go to PubMed...
- White R, Zhou H, Romano P. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003;90:446-455.
Go to original source...
Go to PubMed...